PharmaCyte Biotech, Inc. (PMCB) earnings
PMCB earnings moved a median of +2.48% by the close. Quarterly and annual PMCB reports and results, each read against the price at its own news timestamp. Back to the PMCB overview →
17 measured PMCB earnings events.
Where these PMCB earnings landedvs 17 measured PMCB earnings reactions
| Middle 50% of PMCB earnings reactions | -1.74% to +4.40% |
|---|---|
| Median reaction (to close) | +2.48% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 PMCB earnings events with a measured close landed between -1.74% and +4.40%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | +0.95% | -2.61% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | -1.45% | -0.88% | |
| Form 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form 10-K | +0.00% | +2.48% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jan 31 | SEC filing · Form 10-Q | -0.78% | -0.82% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form 10-Q | +2.42% | +2.88% | |
| Form NT 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form NT | +1.98% | +4.40% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | +0.00% | -6.48% | |
| Form 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form 10-K | -1.17% | +5.53% | |
| Form NT 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form NT | +0.00% | +0.49% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jan 31 | SEC filing · Form 10-Q | -0.63% | -5.06% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | -1.74% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | +0.00% | +5.03% | |
| Form NT 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form NT | +0.00% | +5.03% | |
| Form 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form 10-K | +0.00% | +3.28% | |
| Form NT 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form NT | +0.06% | +2.56% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jan 31 | SEC filing · Form 10-Q | -2.44% | +6.47% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | -3.56% |
Keep exploring
More PMCB: analyst actions → · SEC filings → · PMCB overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.